Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?

Worldwide, there are enormous inequities in cancer control that cause poor outcomes among patients with cancer who live in low- and middle-income countries (LMICs). One of the biggest challenges that oncology faces today is how to increase patient access to expensive, but life-saving, therapies in L...

Descripción completa

Detalles Bibliográficos
Autores principales: Bognar, Cinthia Leite Frizzera Borges, Bychkovsky, Brittany L., Lopes, Gilberto de Lima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493268/
https://www.ncbi.nlm.nih.gov/pubmed/28717715
http://dx.doi.org/10.1200/JGO.2016.005363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493268/
https://www.ncbi.nlm.nih.gov/pubmed/28717715
http://dx.doi.org/10.1200/JGO.2016.005363

Ejemplares similares